Skip to main content

Sphera Funds Management Ltd.

SEC CIK
0001496201
Latest filing
Aug 14, 2026

TSHA holding history

Taysha Gene Therapies, Inc. in every 13F filed by Sphera Funds Management Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TSHA overviewAll 13F holders of TSHAFull Q2 2026 holdings

Shares (Q2 2026)
250,000
Value
$1.70M
% of portfolio
0.2%
Quarters held
4
Since Q2 2025
Holdings of TSHA by Sphera Funds Management Ltd., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026250,000$1.70M0.2%+250,000NewHolders
Q1 20260$00.0%−368,146−100.0%Sold outHolders
Q4 2025368,146$2.02M0.4%−40,000−9.8%ReducedHolders
Q3 2025408,146$1.33M0.3%−11,854−2.8%ReducedHolders
Q2 2025420,000$970.2K0.3%+420,000NewHolders